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ABSTRACT 
Objectives: Non-enzymatic glycation is closely associated with altered mechanical properties of 
connective tissue. Pregnancy, marked with high levels of female hormones, confers unique alteration to 
the mechanical properties of pelvic connective tissues in order to meet their physiological demands. 
However, there are few studies on glycation content and its influence on the mechanical properties of  
pelvic connective tissues during pregnancy. We hypothesise that the glycation content in pelvic tissues 
will change with a corresponding change in their mechanical properties, and that these changes are 
influenced by hormone levels. This study aims to investigate the correlation of vaginal tissue glycation 
content and mechanical property changes during pregnancy in association with the expression of a key 
pregnancy hormone (oestrogen)  receptor, and an antioxidant enzyme, glyoxalase I.  
Study design: A rat vaginal tissue model (tissues from non-pregnant and E15-E18 (last trimester) 
pregnant rats) was used in this study. Mechanical characteristics of vaginal tissues were analysed by a 
ball-indentation technique while modulus and morphology of the collagen fibrils within the tissues 
were measured with atomic force microscopy. A glycation marker, pentosidine, was quantified by a 
high performance liquid chromatography. The expression of oestrogen and glyoxalase I in the tissue 
was qualified by immunochemical staining. The glycosaminoglycan (GAG) concentration difference in 
the tissues were quantified by a biochemical assay. 
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Results: Pregnant rat vaginal tissue was characterised by significantly lower amounts of pentosidine, 
higher oestrogen and glyoxalase I expression with larger creep, lower elastic modulus, thicker fibril 
morphology and higher GAG content than their non-pregnant counterpart. There was a negative 
correlation between pentosidine and vaginal tissue creep. 
Conclusion: There was a reduction in vaginal tissue pentosidine in pregnancy with an associated 
increase in oestrogen receptor and glyoxalase I immunoexpression. Reduced glycation was associated 
with increased creeping of vaginal tissue. Oestrogen may therefore play a role in the increase of the 
vaginal wall’s capacity to stretch through glyoxalase I up-regulation and subsequent glycation 
reduction. The new insight of the correlation of women’s oestrogen level, glycation reaction and pelvic 
tissue mechanical property from this study may enhance our understanding on some pelvic organ 
diseases. 
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INTRODUCTION 
Pregnancy alters vaginal tissue mechanics in preparation for delivery (1,2). The vaginal wall is adapted 
to accommodate delivery of the baby with minimal injury (1,3) and becomes more distensible with a 
significant decrease in stiffness and ultimate load, returning to its pre-delivery state by the end of the 
puerperium (1,2,4). Elevation of certain hormone levels is the hallmark of pregnancy. Oestrogen is a 
notable pregnancy related hormone involved in the remodelling of pelvic connective tissues. It  
influences collagen metabolism in pelvic connective tissues, causing protein breakdown and neo-
synthesis evidenced by an increase in immature collagen crosslinks and decrease in mature crosslinks 
with collagen therapy (5). Oestrogen therapy has resulted in improved fibroblast mitotic activity, 
increased turnover of structural proteins like collagen and increased activity of tissue inhibitors of 
matrix metalloproteinase (6,7). These actions on collagen may influence the proportion of old and new 
collagen within tissue, thereby altering their mechanical properties. 
Older connective tissues contain glycated proteins, nuclei and fatty acids formed by prolonged contact 
of reducing sugars with susceptible amino acids (8).  Glycation occurs by a mailliard reaction in which 
reducing sugars covalently bind to amino acids. Intermediate products of oxidation formed are 
rearranged over months or years into advanced glycation end products (AGEs). Within tissues, this 
process is non-enzymatically regulated. Collagens are prime targets for the glycation process because 
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of their long half life which leads to prolonged contact with reducing sugars. They also contain 
significant amounts of susceptible lysine and arginine residues along their chains (9–11).  
It is well known that ageing is associated with increased tissue glycation where it alters the mechanical 
properties of the connective tissues, resulting in stiffer tissues (12). Age-related pelvic floor disorders 
in women such as pelvic organ prolapse and urinary incontinence are more common after the 
menopause when oestrogen levels are low. Since oestrogen may influence amounts of old and new 
collagen in pelvic tissues, and older connective tissue contains more glycation products, oestrogen 
therefore has the potential to affect the mechanical properties of the tissue by altering glycation content. 
It is, therefore, hypothesized that there is a relationship between hormonal level, glycation content and 
mechanical properties of pelvic tissues. Currently few studies correlate hormone level and glycation 
content in pregnancy. In this study, we aimed to correlate vaginal wall mechanical properties with 
glycation content during pregnancy by utilising multiple new approaches in a rat tissue model.  
MATERIALS AND METHODS 
Species and tissue samples 
Outbred 6-8 month old female Sprague Dawley rats were used following ethical approval by the 
Animal Welfare & Ethical Body Review, in accordance with the Animal act of 2006. Full thickness 
vaginal tissues were obtained from these non-pregnant and E15-E18 (last trimester) pregnant rats post 
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humane with culling by a Schedule 1 method. Both fresh and defrosted tissues frozen at -20C were 
used after the Schedule 1 killing. 
Modulus and creep testing 
The 24 hour creep deformation and modulus of the intact vaginal tissue segments were measured using 
a non-destructive ball indentation technique following a pre-established protocol (13). Briefly, the 
mechanical test device consisted of two transparent plastic O-rings held securely in place by stainless 
steel screwed plates. Whole intact tubular vagina from the rats were dissected by a mid-line incision 
and opened up into a rectangular flat piece prior to mounting between the O-rings. Distension of tissues 
were achieved by central displacement, produced by spherical Teflon or stainless steel balls of weights 
0.027 g and 0.27 g for creep and modulus testing respectively. The deformation images were acquired 
using a microscope with a long focal distance connected to a CCD camera and computer. To obtain 
creep data, deformation images at time 0 and 24 hour were taken with the tissues incubated in a moist 
chamber at 37oC and 5% CO2. The following equation based on the initial displacement, δ, was used 
for elastic modulus, E, measurement (13): 
6w/EhR = 0.075(δ/R)2 + 0.78(δ/R) 
where ‘h’ represents the tissue’s thickness, measured by optical coherence tomography, ‘R’ is the 
radius of the spherical ball (4 mm) and ‘w’ is the weight of the ball.  
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Ageing biomarker detection 
The glycation product, pentosidine, which is formed by the reaction of arginine and lysine with a 
pentose sugar (8) was chosen for detection (14). Freshly dissected vaginal tissue portions from aged-
matched pregnant and non-pregnant rats were hydrolysed in 6 M hydrochloric acid at 110oC over 20 
hours. Hydrolysed samples were redissolved in deionised water and separated using high performance 
liquid chromatography (HPLC, Agilent 1220 LC, USA). Separation occurred in a C-18 250 x 4.60 
analytical column and detection at 325 nm wavelength by an ultraviolet detector. Pure pentosidine 
compound (Caymann Chemical, USA) was used for standard quantification. Pentosidine eluted at 9.6 
minutes in a 30 minute run using gradient ratios of 0.1% trifluoroacetic acid and 80% acetonitrile 
(solvents A and B, respectively) at a flow rate of 1 ml/min with gradient of 0-18% from 0  to 12 
minutes and 100% for 12 to 18 minutes for solution B and 100% - 82% from 1 to 12 minutes of 
solution A. 
Immunochemistry 
Tissues were fixed using 4% paraformadahyde, dehydrated and processed into wax blocks prior to 
sectioning into 6 µm-thick sections in a cryostat and immunostained using conventional 
immunocytochemistry assay. For oestrogen (ER-α) receptor detection, sections were permeabilised 
with triton-X after blocking by bovine serum albumin. Following incubation with mouse monoclonal 
IgG antibody to ER-α (Santa Cruz Biotechnology) directed against the intranuclear steroid receptors, 
8 
 
goat anti-mouse IgG (Life Technologies) was incubated against the primary antibody. Rabbit 
polyclonal glyoxalase I antibody (Abcam, UK) was used to detect its expression with mouse anti-rabbit 
IgG as the secondary antibody. Nuclei were counter-stained by 4',6-diamidino-2-phenylindole (DAPI). 
Nanomechanical properties and Collagen fibril diameter 
Atomic force microscopy (AFM) was conducted using a Bruker Multimode instrument (Nanoscope 
VIII MultiMode AFM, Bruker Nano Inc., CA) equipped with a 150 x 150 x 5m scanner (J-scanner) 
operated with PeakForce Quantitative Nanomechanical Mapping (PFQNM) modality. For PFQNM 
measurements, the spring constant of the cantilever and deflection sensitivity were measured on a clean 
sapphire sample and then, the set up was calibrated with a polymer of known elastic modulus (PSI, 
Vishay Measurements Group, UK) (15). Five m thick vaginal cryosections of pregnant and non-
pregnant rats without fixation were collected onto coverslips and stored at -200C until testing. The 
coverslips were glued to metal support stubs prior to testing. To obtain high resolution images air dried 
sections were used. A silicon nitride tip (Bruker TAP150) with a nominal tip radius of 8 nm and a 5 
N/m spring constant was used for imaging. The elastic modulus for each imaged region of the samples 
was extracted using the Derjaguin–Muller–Toporov (DMT) model (16). Using ImageJ software, 
collagen fibril thickness was measured for 45 fibrils per group. 
Glycosaminoglycan and water content   
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Lyophilized weighed rat vaginal tissues were digested in papain enzyme solution (50 ml of 200 mM 
phosphate buffer containing 1 mM EDTA (pH 6.8), 25 mg papain from papaya latex and 48 mg N-
acetylcysteine (17)). Three hundred μl of digestion solution was added to 6-12 mg dried tissue samples 
and incubated for 16 h at 60°C. Thereafter, 200 μl dimethlymethylene blue (DMMB) solution was 
added to each well of 96 well plate containing 50 μl of samples or standard solution aliquots, followed 
by immediate absorbance reading at 530 nm (BioTec Synergy 2). The standard curve was made by 
using serial dilutions of bovine chondroitin sulphate stock solution. Tissue segments ranging from 4-15 
mg were dried to constant weight. Water content of the tissues was determined as the difference 
between wet and dry tissue weights and expressed as a percentage of the wet weights.  
Statistics 
An unpaired t-test was performed for comparison of means between pregnant and non-pregnant groups, 
after determination of data normality using D’Agostino and Pearson omnibus normality tests. A p-
value below 0.05 indicated statistical significance. In our graphs, statistical significance is indicated at 
three levels: *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001 respectively. Standard error of the mean were 
used to measure variability. Two individual tissue sections per group were studied for collagen fibril 
modulus and diameter (AFM). Other quantified measurements were based on 5 or more pairs of 
vaginal tissue. 
RESULTS  
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Using the indentation ball technique, tissue was deformed over 24 hours with a constant weight. 
Significantly higher deformation was observed in tissue from pregnant rats (p=0.003) as compared with 
non-pregnant rats (Figure 1a). Approximately five times more deformation and 200% lower apparent 
elastic modulus were observed for the pregnant rat vaginal tissue compared with non-pregnant rats 
(Figure 1b). These tissue-level mechanical properties were consistent with nanoscale elastic modulus 
measurements obtained with AFM, showing a trend towards a higher elastic modulus in non-pregnant 
rats (Figure 2a). Moreover, the nano-scale measurements showed distinct differences between the two 
groups (Figure 2b). Fibrils within the pregnant tissue appeared wider and merged as shown in the 2D 
and ‘3D’ images (Figure 3a), they also exhibited more frequent banding, in contrast to the distinctly 
separated fibrils of the non-pregnant group. Fibril diameter in the pregnant group was significantly 
greater than the non-pregnant group (Figure 3b). Fibrils within the pregnant group appeared flatter and 
often merged to form wider ‘fibers’ unlike the fibrils in the non-pregnant group which had more 
separated individual collagen fibers. 
DMMB assay revealed that GAG content was significantly higher in pregnant rat group (p=0.02) than 
in the non-pregnant (Figure 4a) group with corresponding significantly higher water content in the 
tissues (Figure 4b).  
Pentosidine contents per gram of dry tissue for both groups are shown in Figure 5a. Vaginal tissues 
from pregnant rats contained an average of 0.02 mg pentosidine per gram of tissue while tissues from 
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non-pregnant rats contained 0.04 mg pentosidine per gram of tissue. These differences were found to 
be significant (P = 0.04). Good negative correlation (r2= -0.50) was noted between 24 hour creep and 
tissue pentosidine content of the same rats (Figure 5 b). 
Oestrogen receptor and anti-oxidant enzyme, glyoxalase I expression in both tissue groups were 
determined by immunostaining assays as shown in Figures 6a-b. Tissue sections from both groups were 
well nucleated as shown by DAPI staining whilst the intranuclear oestrogen recptors were more 
strongly expressed in the pregnant than the non-pregnant tissue. Location of glyoxalase I enzyme was 
predominantly sub-epithelial and more expressed in the pregnant group. 
DISCUSSION  
Studies on pregnancy induced changes in the latter 2 trimesters of pregnancy have mostly focused on 
cervical changes rather than the vaginal wall alteration. This study reports for the first time that a 
glycation product, pentosidine, was significantly reduced during pregnancy, a high oestrogen state; and 
that this reduction in glycation correlated with higher mechanical creep. Vaginal tissues in pregnancy 
also expressed higher levels of the antioxidant enzyme, glyoxalase I, than did tissues from the non-
pregnant rats. The higher creep behaviour of whole vaginal tissue segments in pregnant rats correlated 
inversely with their modulus and glycation content. Nano-scale examination of the collagen fibers in 
pregnant tissue by AFM supported the bulk mechanics change. The morphology and chemical 
composition changes were observed as significantly thicker collagen fibril diameter and higher GAG 
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content in pregnant tissues. The regulatory relationship between oestrogen and glycation content in 
pregnancy was evidenced in this study. 
Advanced glycation end products (AGEs) accumulate in tissues, typically increasing with age and 
causing connective tissue stiffening (14). Although AGEs are associated with many pathologic states, 
their accumulation within tissues is not always permanent. Macrophages within the body may bind to 
and scavenge AGEs (18). The high oestrogen state in pregnancy associated with reduced AGEs in the 
vaginal wall is congruent with other research. Previous findings have noted a decrease in skin 
autoflourescence (a reflection of advanced glycation) during pregnancy (19). A 50% reduction of 
pentosidine has also been observed in blood vessels under chronic oestradiol therapy (20). Oestrogen 
treatment of vascular endothelial cells reduced advanced glycation-induced inflammation (21). This 
suggests on-going physiologic changes in pregnancy such as modification of connective tissue by 
pregnancy-related hormones. Pregnancy, or states of high oestrogen expression may therefore involve 
mechanisms resulting in AGE cleavage and reduced formation. Relationships between glycation 
products and stiffening of other body tissues such as tendon, intervertebral discs, skin and arteries have 
been studied but for the first time a relationship is demonstrated in vaginal tissues during pregnancy 
(22–24). Other studies have similarly reported the association of high glycation with tissue stiffness 
(22,25). 
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By a constant load procedure a significantly higher creep and lower stiffness of pregnant vaginas was 
observed in this study and is congruent with previous studies. The fibromuscular vaginal wall has 
previously been noted to increase in circumference during pregnancy with apparent collagen reduction 
(4). The vaginal wall and supporting tissues are more distensible during pregnancy, with a decrease in 
stiffness, or modulus, in preparation for delivery with minimal injury (1,2,4). Collagen fibrils within 
the vaginal wall also undergo progressive disorganisation and remodelling through the middle and later 
stages of pregnancy (26). Although there was apparent thickening of the collagen fibrils in this study, 
other research suggests that individual fibril diameter may not account for overall tissue modulus (27). 
Higher tissue modulus typically is the result of crosslinking between fibrils with both enzymatic and 
non-enzymatic (glycation) crosslinks and is reflected in increased stiffness of the collagen fibers and 
tissues (8). The significance of reduced glycation crosslinks observed in pregnant tissues may therefore 
be correlated with  altered mechanical properties of the tissues - reduced stiffness and enhanced creep.  
Crosslink changes are unlikely to account for the increased collagen fibril diameter observed in 
pregnant tissues in our study, leading to consideration of another possible mechanism for the observed 
wider fibrils. Type I collagen fibrils could increase diameter by lateral fusion of fibrils, possibly aiding 
fiber performance at high strain (28). Our AFM images revealed collagen fibrils which appeared fused 
to form the wider fibrils. To further understand the observation, GAGs contents were measured and 
were notably higher in pregnant rat tissues. Previous studies have also noted a progressive increase in 
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GAGs content of pelvic tissues during pregnancy and its loss at delivery (26,29). Certain proteoglycans 
also modulate fibrillogenesis and fiber alignment (30). Studies have shown that removal of GAGs 
results in disorganization of collagen fibrils (31). GAGs present between collagen fibrils in connective 
tissues may aid their arrangement, resisting complete fiber disorganisation during stretching. GAGs 
influence collagen fibril association through methods other than direct chemical or physical 
crosslinking (32), causing an apparent increased fiber diameter and resisting complete deformation 
during sliding. Thus, the higher expression of GAG in pregnancy may serve as a protective measure 
during tissue stretching by preventing complete disorganisation of fibrils. 
In pregnancy, oestrogen may influence tissue glycation by modulating the oxidative stress pathway. 
Glycation is associated with oxidative stress and reactive oxygen species have been shown to trigger 
AGE formation (33,34). Excessive production of reactive oxygen species within the mitochondria of 
cells inhibits glyceraldehyde-3-phosphate dehydrogenase and diverts substrates from glucose 
breakdown pathways to increased AGE formation (35). Oestrogen administration has been associated 
with reduced oxidative damage and glycation induced stress within connective tissues (20,36). 
Oestrogens cause increased expression and activity of antioxidant enzymes and their co-factors (37). 
Reduced oestrogen is associated with decreased amounts of the thiol antioxidant, gluthathione (GSH) 
which is reversed by oestrogen administration (37). Oestrogen also influences the gluthathione-
dependent glyoxalase system through glyoxalase I which plays a role in the removal and prevention of 
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AGEs accumulation by detoxification of methylglycoxal, a reactive dicarbonyl intermediate and AGE 
precursor (34,38). Deficiency in glyoxalase I enzyme has has been implicated in increased AGE 
accumulation within tissues (39). In our study, we noted increased expression of glyoxalase I enzyme 
in the tissues from pregnant rats similar to findings in other studies (40). A high oestrogen level is also 
associated with increased activity of gluthathione peroxidase, a potent antioxidant (41). This would 
lead to more removal of reactive oxygen species and subsequent reduced glycation. Thus, in addition to 
on-going physiologic removal of AGE by macrophages within tissues (42,43), a decrease in glycation 
of tissues resulting in reduced formation of AGEs is expected. Hence states of higher oestrogen such as 
pregnancy or the proliferative phase of the female menstrual cycle would be associated with reduced 
AGEs through a proposed oestrogen-gluthathione-glyoxalase pathway as depicted in Figure 7. As a 
result, whilst oxidative stress promotes AGEs formation, oestrogen increases the activity of glyoxalase 
and GSH leading to stronger detoxification, production of lactoyleglutathione and decreased AGEs. 
This physiologic pathway would also be useful in understanding the pathogenesis of pelvic organ 
prolapse which occurs predominantly in older menopausal women. During the years following 
menopause oestrogen levels decline and this may halt the process of cyclical removal of AGEs which 
should occur during the normal reproductive life of the female. Progesterone is another significant 
hormone during pregnancy. However there is minimal evidence for its influence on AGEs. Further 
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investigation on the effects of progesterone on glycation may however be useful in obtaining a more 
roboust understanding of the effect of pregnancy on AGEs in pelvic tissues. 
This study used a minimally-destructive technique for assessment of vaginal tissue bulk mechanical 
property and employed the AFM technique for the study of collagen fiber mechanics and morphology, 
enabling simultaneous assessment of the global and nano-scale mechanical and structural properties of 
vaginal tissues. The limitation of this study is that it is based on an animal model. It is desirable to 
study human samples, both vaginal and hormonal, to confirm the observations in this study. 
COMMENTS 
This study is the first of its kind and highlights a potential relationship between mechanical changes 
observed in pregnancy and collagen fiber changes within the connective tissue, confirming that 
pregnant vaginal tissues contain lower levels of advanced glycation end products. Glycation  reduction  
may contribute to the increased flexibility (high creep) of pregnant vaginal tissues in association with 
increased GAG levels and collagen fiber fusion. Pregnancy reduced vaginal wall glycation by increased 
levels of the antioxidant enzyme glyoxalase I, and oestrogen, is potentially a major reason for the 
observed changes. These observations generate novel insights into other pathways for vaginal tissue 
mechanical changes during pregnancy and provide some evidence that the alteration of glyoxalase 
concentration by the elevation of oestrogen levels correlates with a reduction in AGEs thus altering 
vaginal tissue flexibility. 
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FIGURE CAPTIONS 
Figure 1 Mechanical properties of intact vaginal tissue segments from pregnant and non-pregnant rats 
measured by the ball indentation technique. (a) 24 hour creep (* p=0.003); (b) Elastic modulus 
(* p= 0.047).  
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Figure 2 AFM measurement of mechanical property. (a) Representative maps showing modulus range 
over a 1.4 m2 area of vaginal tissue sections from pregnant (left) and non-pregnant (right) rats. 
The color bars alongside the images indicate the modulus value; (b) Mean modulus of collagen 
fibrils in the both tissues (p=0.335). 
 
28 
 
 
  
29 
 
Figure 3 AFM measurement of collagen fibril morphology of pregnant and non-pregnant vaginal 
tissues. (a) Representative 2-dimensional (A and B) and 3-dimensional (C and D) images of 
collagen fibrils; (b) The mean diameters of collagen fibrils (*** p=0.000). 15 collagen fibrils 
from 3 x 1.4 m2 regions of 3 x 5 m thick sections have been analysed. Arrows indicate 
merging of the fibrils. 
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Figure 4 (a) GAG content per dry weight of pregnant and non-pregnant rat vaginal tissues (* p 
value=0.015); (b) Percentage water content of pregnant and non-pregnant rat vaginal tissues (* p 
value=0.047) 
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Figure 5 (a) AGE marker level measured from HPLC for the pentosidine content in vaginal tissues 
from pregnant and non-pregnant rats (* p value=0.042); (b) Correlation between pentosidine 
and vaginal tissue creep (r2= -0.50)  
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Figure 6 Immunofluorecence staining images of vaginal tissue sections. (a) Representative images of 
ER- receptor expression; (b) Representative images of glyoxalase I expression. P: pregnant; 
NP: non-pregnant; Tritc: ER-a receptor; FITC: glyoxalse-1; BF: bright field and Dapi: nuclei. 
Scale bars = 50 m.  
 
36 
 
 
  
37 
 
Figure 7 Illustration of AGEs formation inhibition by oestrogen. Oestrogen increases antioxidant 
enzyme and co-factor, glyoxalase I and GSH. In the detoxification processes, intermediate AGE 
precursors, e.g. methylglycoxal, are diverted to other pathways, leading to reduced AGE 
accumulation. 
 
